In January, the Trump administration launched a pilot program called WISeR, which uses artificial intelligence (AI) to decide whether certain types of care for Medicare patients would be approved or denied. Before this program, Medicare did not require prior authorization for such care, meaning doctors could typically provide treatment without waiting for approval. The introduction of AI to handle these decisions sparked controversy, as media reports highlighted a range of problems, including technical glitches, long delays in processing requests, and confusing denials of care. These issues led to frustration among doctors and patients, with some patients reportedly experiencing pain while waiting for necessary treatments. The concerns raised by media outlets were later supported by the Electronic Frontier Foundation (EFF), a digital rights group. The EFF obtained federal documents about the WISeR program through legal action and shared them with the public. These documents included feedback from healthcare providers, some of whom described the system as "a disgrace to the human race." One provider reported instances of patients crying in pain while waiting for care to be approved. These accounts have drawn significant public attention and raised ethical and practical concerns about the use of AI in healthcare decision-making. Lawmakers from both major political parties have been actively questioning the administration about the program and have attempted to halt its operation. In May, the Government Accountability Office (GAO), an independent agency that audits federal programs, issued a report stating that Trump officials had not followed proper procedures when setting up WISeR. This raised questions about the program's legality and whether it should have been implemented in the first place. Despite these findings and the mounting criticism, the program has not been terminated and, in fact, appears to be moving forward with plans to expand its use in the coming years. The controversy surrounding WISeR highlights broader debates about the role of artificial intelligence in healthcare and the need for transparency and accountability in automated decision-making. While the administration defends the program as a way to improve efficiency, critics argue that it risks patient safety and undermines the trust between healthcare providers and the government. As the program continues to evolve, its impact on Medicare beneficiaries and the healthcare system at large remains a topic of intense scrutiny.